Gradient Health’s Counterintuitive MVP Strategy: Why They Sold Before Building

Most founders spend months perfecting their product before approaching customers. Gradient Health did the opposite.

“Just like the way we got started was we took orders first and then went and found the data later,” Joshua Miller revealed in a recent Category Visionaries episode. This unconventional approach helped Gradient Health validate their market for medical imaging data before investing heavily in development.

The strategy emerged from an unexpected source. While brainstorming ideas for fall detection AI, Joshua and his co-founder faced a data problem: “Where do you get a bunch of audio files of people falling over? And the answer is, it doesn’t exist.” Their solution? Have the co-founder repeatedly fall and record it.

This experience revealed a larger opportunity in medical data access. AI companies building healthcare solutions couldn’t simply call hospitals requesting patient data. Instead of spending months building infrastructure first, Gradient Health started selling the solution immediately.

Joshua’s three-month rule crystallizes this philosophy: “If you’re considering starting a startup right now and you can’t reach a sellable MVP in three months, you probably need to pare down your vision a little bit more.” This aggressive timeline forces founders to focus on essential features and market validation.

For founders trapped in development cycles, this might sound reckless, especially in healthcare. But Joshua argues that “startups are built incrementally, not in these huge bumps.” He’s particularly skeptical of extended stealth periods: “Whenever I see a company that’s in stealth, I’m always kind of like, if you’re not doing like really hard science and coming out with a patent portfolio out of nowhere, I’m not sure that stealth always makes sense.”

This sell-first approach proved particularly valuable for navigating the healthcare industry. Rather than building what they thought hospitals wanted, they could verify demand before investment. Their first customer, Cone Health, came through an angel investor connection, providing crucial validation for their approach.

The results speak for themselves. Today, Gradient Health receives nearly 50% of leads through inbound channels, including Fortune 500 companies directly reaching out to their 15-person team. Their recently launched self-service platform gained 130 users in just 30 days.

For B2B founders, especially those in regulated industries, Gradient Health’s experience offers a compelling alternative to traditional product development. Instead of asking “How long until we can start selling?”, perhaps the better question is “What’s the minimum we need to start selling today?”

After all, as Joshua puts it, “A lot of folks I see build things and then go out and try to sell it. I think the right way to do it is to sell things and then go out and try to build it as quick as you can after someone buys it.” In an era of lean startups, it might be time to make sales, not stealth, the default mode.